{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:01:00Z","timestamp":1793070060256,"version":"4.5.0"},"reference-count":60,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism Reviews"],"published-print":{"date-parts":[[2021,7,3]]},"DOI":"10.1080\/03602532.2021.1917599","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:01:42Z","timestamp":1619568102000},"page":"375-383","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacokinetics, toxicological and clinical aspects of ulipristal acetate: insights into the mechanisms implicated in the hepatic toxicity"],"prefix":"10.1080","volume":"53","author":[{"given":"Ricardo Jorge","family":"Dinis-Oliveira","sequence":"first","affiliation":[{"name":"IINFACTS - Institute of Research and Advanced Training in Health Sciences and Technologies, Department of Sciences, University Institute of Health Sciences (IUCS), Advanced Polytechnic and University Cooperative (CESPU), CRL, Gandra, Portugal"},{"name":"Department of Public Health and Forensic Sciences, and Medical Education, Faculty of Medicine, University of Porto, Porto, Portugal"},{"name":"UCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.1.2.261"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(01)00743-2"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2018.11.000033"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.02.014"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1007\/s40278-020-86538-3"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2020.000022"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.02.018"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(03)00118-1"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.04.001"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17225-0"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.07.051"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2019.1680626"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.06.044"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1550070"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103182"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01555-z"},{"key":"CIT0017","unstructured":"European Medicines Agency. 2014. Esmya: summary of product characteristics. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002041\/WC500124085.pdf. London: European Medicines Agency."},{"key":"CIT0018","unstructured":"European Medicines Agency 2018a. Esmya Article-20 procedure \u2013 PRAC assessment report. London: European Medicines Agency. https:\/\/www.ema.europa.eu\/en\/documents\/referral\/esmya-article-20-procedure-prac-assessment-report_en.pdf."},{"key":"CIT0019","unstructured":"European Medicines Agency. 2018b. PRAC recommends new measures to minimise risk of rare but serious liver injury with Esmya for fibroids. London: European Medicine Agency. https:\/\/www.ema.europa.eu\/en\/documents\/referral\/esmya-article-20-procedure-prac-recommends-new-measures-minimise-risk-rare-serious-liver-injury_en.pdf."},{"key":"CIT0020","unstructured":"European Medicines Agency. 2020a. Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk. London: European Medicines Agency. https:\/\/www.ema.europa.eu\/en\/documents\/referral\/ulipristal-acetate-5mg-medicinal-products-article-31-referral-review-started_en.pdf."},{"key":"CIT0021","unstructured":"European Medicines Agency. 2020b. Ulipristal acetate 5mg. Amsterdam: European Medicines Agency. https:\/\/www.ema.europa.eu\/en\/documents\/referral\/ulipristal-acetate-5mg-medicinal-products-article-31-referral-chmp-scientific-conclusions-prac_en.pdf."},{"key":"CIT0022","unstructured":"European Medicines Agency. 2021. Ulipristal acetate 5mg. Amsterdam: European Medicines Agency. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/ulipristal-acetate-5mg-medicinal-products."},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2018.1417389"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23696"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30465"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-00975-8"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12868"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.3109\/00016349009036163"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(87)90083-5"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025725716343"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-387817-5.00001-7"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22272"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.5.1100"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2020.03.020"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181705d0e"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-00964-x"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.148536"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2012.695775"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2020.02.008"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14708"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.11.041"},{"key":"CIT0042","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases. 2012. LiverTox: clinical and research information on drug-induced liver injury. [Updated 2019 May 4]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548392\/."},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i29.8920"},{"key":"CIT0044","first-page":"177","volume":"5","author":"Pohl O","year":"2013","journal-title":"J Bioequivalence Bioavailab"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12098"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12065"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.5414\/CP201789"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1177\/1933719114549850"},{"key":"CIT0049","first-page":"6124628","volume":"2018","author":"Rabe T","year":"2018","journal-title":"Biomed Res Int"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01235"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(98)00388-8"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.162651"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.14740\/gr1188"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz139"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2009.12.012"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03622-9"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11642"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.3109\/15376516.2015.1118715"},{"key":"CIT0059","volume-title":"Use of ulipristal acetate and risk of liver disease: a nationwide cohort study","author":"Yoon EL","year":"2021"},{"issue":"10","key":"CIT0060","first-page":"675","volume":"39","author":"Zimmerman HJ.","year":"1993","journal-title":"Dis Mon"}],"container-title":["Drug Metabolism Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03602532.2021.1917599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T23:13:38Z","timestamp":1633907618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03602532.2021.1917599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7,3]]}},"alternative-id":["10.1080\/03602532.2021.1917599"],"URL":"https:\/\/doi.org\/10.1080\/03602532.2021.1917599","relation":{},"ISSN":["0360-2532","1097-9883"],"issn-type":[{"value":"0360-2532","type":"print"},{"value":"1097-9883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idmr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idmr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-02-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}